These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11271339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
    Woodle ES, Perdrizet GA, So SK, White HM, Marsh JW.
    Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
    [Abstract] [Full Text] [Related]

  • 5. FK 506 treatment of intractable rejection after liver transplantation.
    Jost U, Winkler M, Ringe B, Rodeck B, Pichlmayr R.
    Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES, So S, Jendrisak MD, Perdrizet GA, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract] [Full Text] [Related]

  • 8. FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group.
    Devlin J, Wong P, Williams R, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Bismuth H, Groth C.
    Transpl Int; 1994 Apr; 7 Suppl 1():S64-9. PubMed ID: 11271328
    [Abstract] [Full Text] [Related]

  • 9. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J.
    Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov 15; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract] [Full Text] [Related]

  • 17. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr 15; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract] [Full Text] [Related]

  • 18. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR.
    Transplant Proc; 1998 Jun 15; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS, Cosenza CA, Petrovic LM, Rojter S, Hoffman A, Lopez RR, Meehan M, Pan SH, Vierling J, Makowka L.
    Transplant Proc; 1996 Apr 15; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract] [Full Text] [Related]

  • 20. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr 15; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.